Skip to main content
. 2017 Nov 6;12:168. doi: 10.1186/s13014-017-0903-z

Fig. 6.

Fig. 6

Dosimetric trade-offs of selective DVH criteria for prostate (a) and brain tumor plans (b). Each data point represents the compromise between two dosimetric objectives of one plan; physician (phys.) generated plan results are linked to corresponding clinical (clin.) plan trade-offs. Nine prostate and 11 brain tumor cases are presented (excluding the prostate outlier, see Fig. 4a, and the brain case without brainstem contour). (note: plans which are superior in all presented DVH criteria than the corresponding plan were worse in at least one other dosimetric objective that is not included in the figure)